Authors: BOCOLA V TRECCO MD FABBRINI G PALADINI C SOLLECITO A MARTUCCI N

Citation: V. Bocola et al., ANTIPANIC EFFECT OF FLUOXETINE MEASURED BY CO2 CHALLENGE TEST, Biological psychiatry, 43(8), 1998, pp. 612-615

Authors: BOCOLA V FABBRINI G SOLLECITO A PALADINI C MARTUCCI N

Citation: V. Bocola et al., NEUROLEPTIC-INDUCED PARKINSONISM - MRI FINDINGS IN RELATION TO CLINICAL COURSE AFTER WITHDRAWAL OF NEUROLEPTIC DRUGS, Journal of Neurology, Neurosurgery and Psychiatry, 60(2), 1996, pp. 213-216

Authors: MUKHERJEE S DECINA P BOCOLA V SARACENI F SCAPICCHIO P

Citation: S. Mukherjee et al., DIABETES-MELLITUS IN SCHIZOPHRENIC-PATIENTS, Comprehensive psychiatry, 37(1), 1996, pp. 68-73

Authors: DECINA P MUKHERJEE S BOCOLA V SARACENI F HADJICHRISTOS C SCAPICCHIO P

Citation: P. Decina et al., ADJUNCTIVE TRAZODONE IN THE TREATMENT OF NEGATIVE SYMPTOMS OF SCHIZOPHRENIA, Hospital & community psychiatry, 45(12), 1994, pp. 1220-1223

Authors: TARTARO A FULGENTE T PIZZI CD BONOMO L BOCOLA V ONOFRJ M

Citation: A. Tartaro et al., MRI ALTERATIONS AS AN EARLY FINDING IN CREUTZFELD-JAKOB DISEASE, European journal of radiology, 17(3), 1993, pp. 155-158